Roche’s Actemra helped the sickest Covid-19 patients in a 303-patient study, the trial’s lead investigator said, bolstering what has been mixed evidence that the arthritis drug can be repurposed to help in the pandemic.
If you are not happy with the results below please do another search
50 search results for:
Russia resumed the vaccination of new volunteers in a clinical trial for the country’s flagship Covid-19 Sputnik V vaccine after a short pause, staff at six of 29 trial clinics said, as Moscow moves to accelerate plans to inoculate the population.
Topline results from Gilead Sciences’ Phase II/III CAPELLA trial show that treatment with the company’s long-acting HIV-1 capsid inhibitor lenacapavir reduces HIV viral load better than placebo in heavily treated patients living with multidrug resistant HIV-1 infection.
The number of Covid-19 deaths in the United States crossed 250,000, according to a Reuters tally, as a third coronavirus wave brings a fresh surge in infections and puts immense strain on the healthcare system.
A settlement valued at $8.34 billion was reached between Purdue Pharmaand the Justice Department, which required the drug company to plead guilty to three felonies related to its marketing and distribution of OxyContin, according to the Wall Street Journal.
The U.S. death toll from Covid-19 surpassed a grim new milestone of 250,000 lives lost as New York City’s public school system – the nation’s largest – called a halt to in-classroom instruction, citing a jump in coronavirus infection rates.
Liguori Academy and CMI/Compas Partner to Build Library for Students PHILADELPHIA – November 18, 2020 – Liguori Academy, a nonprofit private high school committed to serving the community, has launched a campaign to build a library for its students, with the support of longtime partner CMI/Compas, strategic media agency and part of WPP (NYSE:WPP). The […]
BioSpace reviews whose wallets got thicker in the biopharma industry, from largest to smallest, during the Nov. 11-17 period
U.S. and European regulators could approve Pfizer and BioNTech’s experimental Covid-19 vaccine as early as mid-December, the German firm’s chief executive said, following the release of positive trial results.
Clarivate Plc released the company’s list of Highly Cited Researchers 2020 that identifies researchers who “demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during the last decade.”